Overview

DIA and RAPS are excited to once again jointly produce 2027 Combination Products in the EU, a summit convening 26–27 January at the Radisson Grand Place in Brussels, Belgium. This highly-interactive event will unite key stakeholders across the field—including representatives from EMA, the European Commission, Notified Bodies, National Competent Authorities and Industry—to explore a coordinated drug and device approach to incentivise competitive innovation in Europe.

Throughout the summit, experts will exchange ideas via action-oriented working groups that stimulate ideation and innovation around designing solutions for pragmatic implementation.

Don’t forget to arrive early to join us for a special preconference workshop on 25 January focused on Introduction to Combination Products in the EU: Regulatory and Practical Insights (separate fee required).

Check the meeting web pages and registration details here

Participant Testimonial

An impressive initiative by the organizers to bring together all parties involved in in-vitro diagnostics and medical devices for decision-making, resulting in an exceptionally focused group. – Ana Trullas – European Medicines Agency

Program Committee

Gert Bos, PhD, MSc Chief Scientific Oficer, Executive Director, Partner
Qserve Group B.V., Netherlands
Christelle Bouygues, PharmD Senior Regulatory Affairs Officer
European Medicines Agency, Netherlands
Tim Chesworth Senior Director Regulatory Affairs
Novartis, United Kingdom
Andreas Emmendoerffer, DrMed, PhD Principal Regulatory Program Director - Device and Combination Products
Roche Pharma LTD, Switzerland
Sabina L. Hoekstra-van den Bosch Global Director Regulatory Strategy
TÜV SÜD Nederland B.V., Netherlands
Amanda Matthews Senior Director, GCMC for Combination Products & Medical Devices
Pfizer R&D UK, Ltd, United Kingdom
Thomas Wejs Møller, MBA, MPA Senior Director Global Regulatory Affairs - Devices, Combination Products, Digit
Novo Nordisk, Denmark
Jonathan Sutch, PhD Principal Medicinal Technical Specialist
BSI Group, United Kingdom
Sophie Tabutin EMEA Regulatory Affairs Leader
W.L. Gore & Associates, France